~ Company Delivers 10th Consecutive Quarter of Strong Earnings Growth ~ ~ Record Revenue Growth of $63.0 Million, Up 124% Y/Y ~ ~ GAAP Net Income of $7.1 Million ~ ~ Adjusted Net Income Up 60% Year-over-Year to $23.6 Million ~ ~ Adjusted EBITDA Grew 127% Year-over-Year to $37.9 Million ~ ~ Increases 2025 Outlook Above Prior Range; Now Expecting Year-over-Year Adjusted Net Income Growth Between 72% & 81% ~ ~ Post Quarter End, Company Completes Two Major Milestones with Strategic Acquisition of AccuQuote & $ ...

AUSTIN, Texas, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Commerce (Nasdaq: CMRC), an open, intelligent ecosystem of technology solutions and the parent company of leading ecommerce platform BigCommerce, today announced that Gartner has recognized BigCommerce as a Challenger in the 2025 Gartner Magic Quadrant for Digital Commerce Platforms. BigCommerce was again recognized as a Challenger for the sixth consecutive year. “We believe BigCommerce’s placement reflects the strength of our innovative approach backed by ra ...

Oncology program advancing with data expected in the fourth quarter 2025 BEACON-IPF close out activities to be completed in the fourth quarter 2025 SOUTH SAN FRANCISCO, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company focused on the discovery and development of integrin-based therapeutics, today provided a corporate update and reported third quarter 2025 financial results. “During the third quarter, our team continued to advance our p ...

LOS ANGELES, Nov. 06, 2025 (GLOBE NEWSWIRE) -- BlackLine, Inc. (Nasdaq: BL), today announced financial results for the third quarter ended September 30, 2025. “BlackLine’s third-quarter results, with increasing revenue growth, solid margins, and strong free cash flow, demonstrate that our focus on improved execution is taking hold,” said Owen Ryan, CEO of BlackLine. “The deliberate changes we've made with our processes, technology, and people across our Product, Go-To-Market, and Operations teams are beginn ...

Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First Line (1L) Consolidation in Large B-Cell Lymphoma (LBCL) ALPHA3 Positions Company at the Forefront of MRD-guided, Earlier-Line Oncology TreatmentAdditional Sites in Australia and South Korea Expected to Open in early 2026Scheduled Futility Analysis, Focused on MRD Conversion Between Study Arms, on Track for 1H 2026 Phase 1 RESOLUTION Trial with ALLO-329 in Autoimmune Disease (AID) ALLO-329, a Dual CD19/CD70 CAR, Harnesses the D ...

Fortman Sale Nets a $3 Million Gain and Provides Capital to Significantly Reduce Long-Term Debt Company Progresses Digital Asset Treasury Initiative to Support Capital Appreciation Model Company on Track to Issue First Dividend in Its History — $0.03 Per Share Special Dividend Payable December 2, 2025 Company to Host Conference Call Today at 4:30 PM Eastern Time LAKEWOOD, N.J., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (Nasdaq: RELI) (“Reliance”, “we” or the “Company”) today reported it ...

MENLO PARK, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients’ lives, today reported financial results for the third quarter ended September 30, 2025, and raised its revenue guidance and reduced its adjusted operating expense guidance, both for full year 2025. Recent Financial and Business ...

VALENCIA, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions (“AVITA Medical,” or the “Company”), today reported financial results for the third quarter ended September 30, 2025. Financial Results Commercial revenue of $17.1 million, representing a 13% decrease compared to the same period in 2024.Cash, cash equivalents, and marketable securities totaled $23.3 million as of Sept. 30, 2025.O ...

ATHENS, Greece and NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Heidmar Maritime Holdings Corp. (the "Company" or "Heidmar") (NASDAQ: HMR) today reported its results for the quarter and nine-month period ended September 30, 2025. Third Quarter 2025 Highlights Total revenues of $15.6 million, up 117%, from $7.2 million in Q3 2024.Net income from continuing operations attributable to shareholders of $1.2 million or $0.02 per share.Adjusted net income from continuing operations of $1.8 million, which excludes $ ...

SAN JOSE, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Nutanix, Inc. (NASDAQ: NTNX), a leader in hybrid multicloud computing, today announced that it will report its financial results for the first quarter of fiscal year 2026, which ended October 31, 2025, after U.S. markets close on Tuesday, November 25, 2025. Nutanix will host a conference call and earnings webcast beginning at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on the same day to discuss the company’s financial results. Interested parties may a ...